Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.31 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 08:00PM GMT
Release Date Price: $89.69 (-3.56%)
Tejas Rajeev Savant
JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. My name is Tejas Savant, and I work in the life sciences team here at JPMorgan. It's my pleasure this afternoon to introduce Kevin Conroy, CEO of Exact Sciences. After Kevin's presentation and after lunch at 1:30 p.m., there will be a breakout with the management team in the Olympic Room.

And with that, I'd like to hand it over to Kevin.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Last month, I attended the San Antonio Breast Cancer Symposium, which is the leading gathering of breast cancer oncologists and researchers in the world. And I left that meeting with a really important insight that we'll talk about later.

Thanks to Tejas, Tycho and JPMorgan, and welcome all of you and to those who are listening on the webcast.

We have a safe harbor statement. We will be making forward-looking statements.

Oncology is rapidly changing, and cancer diagnostics is fueling that change. At

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot